Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 1/2004

01-01-2004

Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer

Authors: Gaynor Davies, Giles H. Cunnick, Robert E. Mansel, Malcolm D. Mason, Wen G. Jiang

Published in: Clinical & Experimental Metastasis | Issue 1/2004

Login to get access
Metadata
Title
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer
Authors
Gaynor Davies
Giles H. Cunnick
Robert E. Mansel
Malcolm D. Mason
Wen G. Jiang
Publication date
01-01-2004
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 1/2004
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/B:CLIN.0000017168.83616.d0

Other articles of this Issue 1/2004

Clinical & Experimental Metastasis 1/2004 Go to the issue

OriginalPaper

p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases

OriginalPaper

Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice

OriginalPaper

Instructions for authors

OriginalPaper

An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer

OriginalPaper

Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer

OriginalPaper

Measurement of tumor load and distribution in a model of cancer-induced osteolysis: A necessary precaution when testing novel anti-resorptive therapies
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits